Mucositis in head and neck cancer patients undergoing radiochemotherapy
DOI:
https://doi.org/10.1590/S0080-62342011000600009Keywords:
Head and neck neoplasms, Radiotherapy, Drug therapy, Mucositis, Oncologic nursingAbstract
The objective of present study was to classify oral mucositis according to the Common Toxicity Criterion (CTC) international parameters in head and neck tumor patients simultaneously treated with radio and chemotherapy, and characterize a patient profile in our area, observing the individuals' habits, tumor characteristics, treatment protocol and acute reaction intensity. Fifty patients undergoing simultaneous 66 to 70 Gy megavoltage radiotherapy and cisplatin/carboplatin chemotherapy were evaluated in this study. Weekly evaluations of the degree of mucositis were perfoemed according to CTC, a four-degree ordinal scale; 36% of all patients and 100% of those with diabetes discontinued treatment due to mucositis, showing that this pathology contributes to the severity of mucositis.Downloads
Download data is not yet available.
Downloads
Published
2011-12-01
Issue
Section
Original Article
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Santos, R. C. S., Dias, R. S., Giordani, A. J., Segreto, R. A., & Segreto, H. R. C. (2011). Mucositis in head and neck cancer patients undergoing radiochemotherapy. Revista Da Escola De Enfermagem Da USP, 45(6), 1338-1344. https://doi.org/10.1590/S0080-62342011000600009